Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AgriZeroNZ is a public-private joint venture based in New Zealand dedicated to accelerating the development and adoption of technologies that reduce agricultural greenhouse gas emissions. The company operates as an investment and scaling vehicle, targeting breakthrough solutions in methane and nitrous oxide reduction for livestock. Its portfolio includes high-impact projects such as methane vaccines, small molecule inhibitors, and microbial therapies designed to suppress methanogens in the ruminant gut. By partnering with global biotechnology firms and research institutions, AgriZeroNZ aims to provide farmers with practical, scalable tools to meet climate targets while maintaining agricultural productivity. The entity is backed by significant funding from both the New Zealand government and major industry players in the agribusiness sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AgriZeroNZ.